kaempferol

Overview

Kaempferol is a naturally occurring flavonol belonging to the 2-phenylchromane flavonoid class, widely distributed across fruits, vegetables, and medicinal plants. It is found in dietary sources such as kale, broccoli, tea, and a range of botanical extracts, and has been isolated from species including Carissa macrocarpa, Moringa oleifera, and Anoectochilus roxburghii. Structurally, kaempferol frequently occurs in plant tissues as flavonoid glycosides, where it is conjugated with various sugar moieties, and can be released as a free aglycone through enzymatic or fermentative processing. Its pharmacological profile is broad, encompassing anti-inflammatory, antioxidant, antifibrotic, anticancer, and antimicrobial activities, making it a subject of sustained interest across multiple therapeutic domains.

The mechanism of action of kaempferol is multifactorial. It modulates the expression of proinflammatory cytokines including Interleukin 1 beta and IL18, suppresses oxidative stress through upregulation of enzymes such as superoxide dismutase, and attenuates extracellular matrix degradation in degenerative and fibrotic conditions. Kaempferol has also been shown to interact with key signaling nodes including TP53, Prostaglandin-endoperoxide synthase 2, TLR4/P2X7-NLRP3 signaling pathway components, and caspase cascades. Despite this promising pharmacological breadth, its clinical translation has historically been constrained by poor aqueous solubility and limited bioavailability, driving active research into advanced delivery systems.

Focus of Latest Publications

Recent publications reveal kaempferol as a multitarget bioactive compound with broad therapeutic applications across inflammatory, metabolic, and neurodegenerative diseases. Research has investigated its efficacy in rheumatoid arthritis, hepatocellular carcinoma, intervertebral disc degeneration, systemic sclerosis, amyotrophic lateral sclerosis, psoriasis, and oral wound healing. Mechanistically, kaempferol modulates several interconnected signaling pathways implicated in disease pathogenesis, including MAPK, AKT-mTOR, NLRP3 inflammasome, STING/NF-κB, and oxidative stress responses, positioning it as a promiscuous modulator of inflammatory and metabolic dysfunction.

In inflammatory and autoimmune disorders, kaempferol exerts protective effects through multipronged mechanisms. In rheumatoid arthritis, kaempferol suppressed pro-inflammatory cytokines (IL-1β, TNF-α, IL-17A, IL-18) and cartilage-degrading enzymes (MMP-13), with effects comparable to methotrexate in nanoparticle formulations. When incorporated into traditional Chinese medicine formulas, kaempferol inhibited NLRP3/Caspase-1/GSDMD-mediated pyroptosis in rheumatoid arthritis cells and animal models, while simultaneously targeting the STING/NF-κB pathway to suppress skin inflammation and angiogenesis in psoriasis. For intervertebral disc degeneration, kaempferol downregulated three core pathogenic genes—STAT1, CASP1, and NOX4—while restoring extracellular matrix components and suppressing matrix-degrading enzymes in nucleus pulposus cells.

Kaempferol's therapeutic potential extends to metabolic and neurodegenerative disease states through distinct molecular mechanisms. In hepatocellular carcinoma cells, kaempferol inhibited glycolysis and proliferation by suppressing the AKT-mTOR pathway and downregulating glycolytic rate-limiting enzymes (PKM2, HK2), while reducing glucose uptake and lactate production. In amyotrophic lateral sclerosis models, kaempferol protected motor neurons from ferroptosis by upregulating antioxidant defense proteins (GPX4, SLC7A11) while downregulating pro-ferroptotic factors (ACSL4), preserving neuronal and mitochondrial integrity. For systemic sclerosis-related skin fibrosis, kaempferol suppressed myofibroblast activation and downregulated TGF-β/Smad signaling pathways, and studies identified kaempferol as a participant in glucose and lipid metabolism regulation.

A major research focus has been overcoming kaempferol's inherently poor solubility and bioavailability through advanced delivery systems. Multiple studies employed nanoparticle formulations—including solid lipid nanoparticles, liposomes, liposome-exosome composites, zein-coated liposomes, and injectable hydrogels—which significantly enhanced drug stability, cellular uptake, and biological activity. These delivery innovations improved kaempferol's therapeutic efficacy in multiple disease models, with nanoparticle-encapsulated formulations demonstrating superior antioxidant capacity, reduced inflammatory marker expression, and enhanced wound healing compared to free kaempferol, establishing nanotherapeutic strategies as a promising approach to unlock kaempferol's therapeutic potential.

Key Publications

• NEWJun Integrative single-cell profiling and explainable AI identify monocyte-metabolic signatures as diagnostic biomarkers and candidate therapeutic targets in tuberculosis. (Archives of microbiology, 2026, PMID 42329418): "Furthermore, computational molecular docking models suggested that the candidate phytochemicals galangin and kaempferol exhibit strong theoretical binding affinities within the catalytic pockets of IL1B and ATG3."
• NEWJun Exploration of the Key Mechanism by Which Kaempferol Inhibits Glycolysis in Hepatocellular Carcinoma Cells via the AKT-mTOR Pathway. (FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026, PMID 42322592): "Kaempferol shows potential in suppressing HCC progression via glycolysis regulation, yet its molecular targets and mechanisms are unclear."
• NEWJun Identification of potential targets of kaempferol for the treatment of intervertebral disc degeneration based on network pharmacology and multi-omics analysis. (Naunyn-Schmiedeberg's archives of pharmacology, 2026, PMID 42283840): "Previous studies have demonstrated that kaempferol exerts potent anti-inflammatory effects by modulating pro-inflammatory cytokine expression and attenuating extracellular matrix degradation in degenerated intervertebral discs."
• NEWJul Dual targeting of cutaneous inflammation and vasculopathy via STING-NF-κB blockade underlies the anti-psoriatic efficacy of Yinxie Granules. (Chinese journal of natural medicines, 2026, PMID 42285688): "Quercetin and kaempferol were identified as the primary STING-modulating components in YXKL, binding to STING proteins and inhibiting downstream pathway activation."
• May Kaempferol-loaded solid lipid nanoparticles attenuate cartilage degradation and inflammation by modulating the expression of pro and inflammatory cytokines, MMP-13 and oxidative stress markers in adjuvant induced arthritic rats. (Inflammopharmacology, 2026, PMID 42184086): "Although kaempferol exhibits strong anti-inflammatory and antioxidant activities, its therapeutic application is limited by poor solubility and bioavailability."
• Jun Targeting lipid nanoparticle mediated co-delivery of edaravone and kaempferol for amyotrophic lateral sclerosis therapy. (Nanoscale, 2026, PMID 42171198): "the natural compound kaempferol has been demonstrated to inhibit neuronal ferroptosis."
• Jun A bioengineered extracellular vesicle-based platform for targeted codelivery and multi-mechanistic therapy of skin fibrosis. (International journal of pharmaceutics, 2026, PMID 42107749): "Kaempferol (K) has promising antifibrotic activity but is limited by poor solubility and delivery efficiency."
• May The "Tianyu" Formulation Alleviates Rheumatoid Arthritis by Modulating the NLRP3/Caspase-1/GSDMD-Mediated Pyroptosis Pathway. (FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026, PMID 42033182): "...molecular docking showed that all five major compounds (Apigenin, Isorhamnetin, Kaempferol, Quercetin, and Salidroside) bound well to NLRP3, Caspase-1, and GSDMD, with all binding energies below -5 kcal/mol."
• Apr Zein-coated versus zein-inserted kaempferol liposomes: enhancing bitterness masking, stability, and bioaccessibility. (Food chemistry, 2026, PMID 42025050): "Kaempferol, a plant flavonoid with antioxidant, anti-inflammatory, and anti-allergenic bioactivities, has limited use in functional foods due to its bitterness and low bioavailability."
• May A self-healing injectable PF127-gelatin bioadhesive sealant with antioxidant and antibacterial activities for accelerated oral ulcer repair. (Journal of materials chemistry. B, 2026, PMID 41995139): "Kaempferol was incorporated into the hydrogel matrix, and the resulting Kae@FG hydrogel exhibited antioxidant and antibacterial activities."